Squarepoint’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Buy |
+29,729
| New | +$37.5K | ﹤0.01% | 2637 |
|
|
2024
Q3 | – | Sell |
-68,599
| Closed | -$113K | – | 2613 |
|
|
2024
Q2 | $113K | Sell |
68,599
-101,325
| -60% | -$166K | ﹤0.01% | 2245 |
|
|
2024
Q1 | $873K | Buy |
169,924
+77,256
| +83% | +$397K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $531K | Buy |
92,668
+13,723
| +17% | +$78.6K | ﹤0.01% | 1664 |
|
|
2023
Q3 | $377K | Sell |
78,945
-16,967
| -18% | -$81.1K | ﹤0.01% | 1787 |
|
|
2023
Q2 | $408K | Buy |
95,912
+24,334
| +34% | +$103K | ﹤0.01% | 1702 |
|
|
2023
Q1 | $380K | Sell |
71,578
-59,980
| -46% | -$318K | ﹤0.01% | 1577 |
|
|
2022
Q4 | $826K | Buy |
+131,558
| New | +$826K | ﹤0.01% | 1202 |
|
|
2022
Q3 | – | Sell |
-40,171
| Closed | -$218K | – | 2144 |
|
|
2022
Q2 | $218K | Buy |
+40,171
| New | +$218K | ﹤0.01% | 1700 |
|
|
2022
Q1 | – | Sell |
-76,691
| Closed | -$1.16M | – | 2326 |
|
|
2021
Q4 | $1.16M | Buy |
76,691
+1,691
| +2% | +$25.5K | ﹤0.01% | 1145 |
|
|
2021
Q3 | $1.79M | Buy |
+75,000
| New | +$1.79M | 0.01% | 834 |
|